These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1378925)

  • 1. Neutralization of bleomycin hydrolase by an epitope-specific antibody.
    Morris G; Mistry JS; Jani JP; Mignano JE; Sebti SM; Lazo JS
    Mol Pharmacol; 1992 Jul; 42(1):57-62. PubMed ID: 1378925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin hydrolase activity in pulmonary cells.
    Lazo JS; Merrill WW; Pham ET; Lynch TJ; McCallister JD; Ingbar DH
    J Pharmacol Exp Ther; 1984 Dec; 231(3):583-8. PubMed ID: 6209387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of fluoromycin: a novel fluorescence-labeled derivative of talisomycin S10b.
    Mistry JS; Jani JP; Morris G; Mujumdar RB; Reynolds IJ; Sebti SM; Lazo JS
    Cancer Res; 1992 Feb; 52(3):709-18. PubMed ID: 1370650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family.
    Sebti SM; Mignano JE; Jani JP; Srimatkandada S; Lazo JS
    Biochemistry; 1989 Aug; 28(16):6544-8. PubMed ID: 2477059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleomycin hydrolase activity and cytotoxicity in human tumors.
    Lazo JS; Boland CJ; Schwartz PE
    Cancer Res; 1982 Oct; 42(10):4026-31. PubMed ID: 6179595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.
    Wassermann K; Zwelling LA; Lown JW; Hartley JA; Nishikawa K; Lin JR; Newman RA
    Cancer Res; 1990 Mar; 50(6):1732-7. PubMed ID: 1689610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
    Sebti SM; Jani JP; Mistry JS; Gorelik E; Lazo JS
    Cancer Res; 1991 Jan; 51(1):227-32. PubMed ID: 1703034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of neutral cysteine protease bleomycin hydrolase and its localization in rat tissues.
    Kamata Y; Itoh Y; Kajiya A; Karasawa S; Sakatani C; Takekoshi S; Osamura RY; Takeda A
    J Biochem; 2007 Jan; 141(1):69-76. PubMed ID: 17158865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserum.
    Kuo SM; Kondo Y; DeFilippo JM; Ernstoff MS; Bahnson RR; Lazo JS
    Toxicol Appl Pharmacol; 1994 Mar; 125(1):104-10. PubMed ID: 7510428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New monoclonal antibodies against the putative immunosuppressive site of retroviral p15E.
    Lang MS; Oostendorp RA; Simons PJ; Boersma W; Knegt P; van Ewijk W
    Cancer Res; 1994 Apr; 54(7):1831-6. PubMed ID: 7511054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-epitope antibody, a novel site-directed antibody against human acetylcholinesterase.
    Zhang XM; Liu G; Sun MJ
    Acta Pharmacol Sin; 2004 Apr; 25(4):431-5. PubMed ID: 15066208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation.
    He Q; Skog S; Wang N; Eriksson S; Tribukait B
    Eur J Cell Biol; 1996 Jun; 70(2):117-24. PubMed ID: 8793383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
    Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB
    Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, structural, and immuno-analytical properties of antigenic bioconjugates comprising a beta-amyloid-plaque specific epitope.
    Manea M; Przybylski M; Hudecz F; Mezö G
    Biopolymers; 2008; 90(2):94-104. PubMed ID: 18183582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificity of bleomycin hydrolase.
    Sebti SM; DeLeon JC; Ma LT; Hecht SM; Lazo JS
    Biochem Pharmacol; 1989 Jan; 38(1):141-7. PubMed ID: 2462878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergenic and antigenic determinants of latex allergen Hev b 1: peptide mapping of epitopes recognized by human, murine and rabbit antibodies.
    Chen Z; Van Kampen V; Raulf-Heimsoth M; Baur X
    Clin Exp Allergy; 1996 Apr; 26(4):406-15. PubMed ID: 8732237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of bleomycin hydrolase with a monoclonal antibody and its characterization.
    Nishimura C; Tanaka N; Suzuki H; Tanaka N
    Biochemistry; 1987 Mar; 26(6):1574-8. PubMed ID: 3109467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum.
    Gonzalez-Gronow M; Cuchacovich M; Llanos C; Urzua C; Gawdi G; Pizzo SV
    Cancer Res; 2006 Dec; 66(23):11424-31. PubMed ID: 17145889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification, characterization, and amino acid composition of rabbit pulmonary bleomycin hydrolase.
    Sebti SM; DeLeon JC; Lazo JS
    Biochemistry; 1987 Jul; 26(14):4213-9. PubMed ID: 3117099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.